• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

March 20, 2020

View Archived Issues

Comprehensive look identifies insulin autoantigens

Read More

Versatope selects VT-105 influenza vaccine candidate for clinical development

Read More

AI-guided discovery of potent and selective oral p300/CBP histone acetyltransferases inhibitors

Read More

Expression of broadly neutralizing anti-HIV Abs by aerosol delivery of synthetic mRNA to the vagina

Read More

Cadent opens phase II study of CAD-1883 for spinocerebellar ataxia

Read More

Grant supports Bloom's development of microbiota-based therapies for ALS

Read More

Algernon supports phase II study of ifenprodil for coronavirus infection

Read More

First patient dosed in phase II study of nNK cells for the treatment of MCC

Read More

Researchers identify miRNAs associated with NAFLD in adolescents with obesity

Read More

Almonertinib receives approval in China for EGFR T790M-mutant NSCLC

Read More

Phosphatidylinositol 3-kinase inhibitors disclosed by BeiGene

Read More

Shanghai Institute of Materia Medica, Shaoxing Zeroin Biomedicines patent TREK-1 blockers

Read More

Jiangsu Chia Tai Tianqing Pharmaceutical Group, Medshine Discovery describe drugs targeting CRBN

Read More

Roivant seeks to advance development of gimsilumab for COVID-19-related ARDS

Read More

New IRAK-4 inhibitors identified at Zhejiang Hisun Pharmaceutical

Read More

Shanghai Maxinovel Pharmaceuticals synthesizes new adenosine A2A receptor antagonists

Read More

Positive topline data for pivotal phase III FLASH study of SGX-301

Read More

Aqualung Therapeutics advances development of ALT-100 for ARDS and VILI

Read More

Phase I data reported for BI-836826 in NHL

Read More

Desmopressin shows promise for the management of bleeding in rectal cancer

Read More

Targeting glycosylated PD-1 induces potent antitumor immunity

Read More

FDA approves Epclusa for pediatric patients with hepatitis C

Read More

Polarisqb partners with Fujitsu on drug discovery

Read More

Lexicon announces early close-out of long-term outcome studies of sotagliflozin

Read More

Promising data reported on favipiravir for COVID-19 in China

Read More

Ridgeback and DRIVE partner to develop EIDD-2801 for COVID-19

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe